Magellan Health Inc
MGLNDelisted Jan 4, 2022- Industry
- Services-Hospitals
- SEC CIK
- 0000019411
Magellan Health Inc was delisted on Jan 4, 2022; its insiders filed their last Form 4 on Jan 4, 2022; 177 institutions reported holding it in 13F filings for Q4 2021, worth $2.50B in total; Starboard Value was the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 11:03 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2020! | FY2019! | FY2018! | FY2017! | FY2016! |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2021 | Feb 28, 2020 | Feb 28, 2019 | Feb 27, 2018 | Feb 24, 2017 |
| Revenue | $4.58B | $7.16B | $7.31B | $5.84B | $4.84B |
| Cost of revenue | $2.18B | $1.90B | $2.28B | $2.21B | $1.82B |
| Gross profit | $144.0M | $252.7M | $228.0M | $310.9M | $301.8M |
| Interest expense | $30.9M | $36.2M | $35.4M | $26.0M | $10.2M |
| Income tax | -$44.5M | $24.9M | $19.0M | $25.1M | $69.7M |
| Net income | $382.3M | $55.9M | $24.2M | $110.2M | $77.9M |
| EPS, basic | $15.14 | $2.31 | $0.99 | $4.72 | $3.36 |
| EPS, diluted | $14.98 | $2.28 | $0.97 | $4.51 | $3.22 |
| Weighted shares, basic | 25.3M | 24.2M | 24.3M | 23.3M | 23.2M |
| Weighted shares, diluted | 25.5M | 24.6M | 25.0M | 24.4M | 24.2M |
| Margins and growth | |||||
| Gross margin | 3.1% | 3.5% | 3.1% | 5.3% | 6.2% |
| Net margin | 8.4% | 0.8% | 0.3% | 1.9% | 1.6% |
| Revenue growth, year over year | −36.1% | −2.1% | +25.3% | +20.7% | +5.2% |
| Net income growth, year over year | +583.9% | +131.2% | −78.1% | +41.5% | +147.9% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2021 | Feb 28, 2020 | Feb 28, 2019 | Feb 27, 2018 | Feb 24, 2017 |
| Cash and equivalents | – | – | $272.3M | $398.7M | $304.5M |
| Accounts receivable | $743.5M | $890.1M | $756.1M | $660.8M | $606.8M |
| Inventory | $43.3M | $45.0M | $40.8M | $40.9M | $59.0M |
| Total current assets | $2.16B | $1.67B | $1.55B | $1.48B | $1.32B |
| Property, plant and equipment | – | $138.4M | $150.7M | $158.6M | $172.5M |
| Goodwill | $873.8M | $1.02B | $1.02B | $1.01B | $742.1M |
| Intangible assets | $79.7M | $167.3M | $231.9M | $268.3M | $186.2M |
| Total assets | $3.36B | $3.09B | $2.98B | $2.96B | $2.44B |
| Accounts payable | $137.4M | $88.4M | $72.1M | $74.3M | $95.6M |
| Total current liabilities | $737.6M | $910.1M | $898.9M | $892.3M | $1.09B |
| Total liabilities | $1.46B | $1.69B | $1.69B | $1.68B | $1.34B |
| Shareholders' equity | $1.87B | $1.40B | $1.29B | $1.28B | $1.10B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 26, 2021 | Feb 28, 2020 | Feb 28, 2019 | Feb 27, 2018 | Feb 24, 2017 |
| Operating cash flow | $450.8M | $115.8M | $164.8M | $162.3M | – |
| Capital expenditures | $75.5M | $60.4M | $68.3M | $57.2M | $60.9M |
| Free cash flow | $375.3M | $55.4M | $96.6M | $105.0M | – |
| Depreciation and amortization | $98.4M | $131.5M | $132.7M | $115.7M | $106.0M |
| Stock-based compensation | $25.2M | $25.5M | $29.5M | $39.1M | $37.4M |
| Share buybacks | – | $4.13M | $62.6M | $21.8M | $106.8M |
| Investing cash flow | $678.9M | -$19.5M | -$128.4M | -$316.4M | – |
| Financing cash flow | $13.1M | -$43.4M | -$162.8M | $248.3M | – |
| Net change in cash | $1.03B | $52.9M | -$126.4M | $94.2M | – |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.5% | 0.4% | 0.4% | 0.7% | 0.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Sep 30, 2021 | 26.3M | +2.8% | SEC |
| Jun 30, 2021 | 26.3M | +3.8% | SEC |
| Apr 16, 2021 | 26.2M | +4.7% | SEC |
| Mar 31, 2021 | 26.1M | +4.6% | SEC |
| Feb 19, 2021 | 26.0M | +5.1% | SEC |
| Sep 30, 2020 | 25.6M | +4.7% | SEC |
| Jun 30, 2020 | 25.3M | +3.7% | SEC |
| Mar 31, 2020 | 25.0M | +3.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.